Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis

Journal of Neuroimmunology

Volumn 277, Issue 1-2, 2014, Pages 13-17

  Yan, Weixing ^a   Nguyen, Toan ^a   Yuki, Nobuhiro ^b   Ji, Qiuhong ^c   Yiannikas, Con ^a   Pollard, John D ^a   Mathey, Emily K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NANTONG UNIVERSITY   (China)

Author keywords

Autoantibody; Chronic inflammatory demyelinating polyneuropathy; Guillain Barr syndrome; Neurofascin; Nodes of Ranvier

Indexed keywords

AUTOANTIBODY; NEUROFASCIN; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; GANGLIOSIDE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NERVE GROWTH FACTOR; NEUROFIBROMIN; NFASC PROTEIN, HUMAN;

ACUTE MOTOR AXONAL NEUROPATHY; ADOPTIVE TRANSFER; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DISEASE EXACERBATION; EXPERIMENTAL AUTOIMMUNE NEURITIS; GUILLAIN BARRE SYNDROME; HUMAN; IN VIVO STUDY; NERVE CONDUCTION; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOLOGY; LEWIS RAT; MALE; NONPARAMETRIC TEST; PASSIVE IMMUNIZATION; PATHOLOGY; PATHOPHYSIOLOGY; POLYRADICULONEUROPATHY; RAT; SCIATIC NERVE; T LYMPHOCYTE; TIME; TOXICITY;

ANIMALS; AUTOANTIBODIES; CELL ADHESION MOLECULES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNIZATION, PASSIVE; MALE; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NERVE GROWTH FACTORS; NEURAL CONDUCTION; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; NEUROFIBROMIN 1; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RATS; RATS, INBRED LEW; SCIATIC NERVE; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TIME FACTORS;

EID: 84918770878     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.09.012     Document Type: Article

References (27)

1. Buttermore E.D., Thaxton C.L., Bhat M.A. Organization and maintenance of molecular domains in myelinated axons. J. Neurosci. Res. 2013, 91:603-622.
2. Cifuentes-Diaz C., Dubourg O., Irinopoulou T., Vigny M., Lachkar S., Decker L., Charnay P., Denisenko N., Maisonobe T., Leger J.M., Viala K., Hauw J.J., Girault J.A. Nodes of Ranvier and paranodes in chronic acquired neuropathies. PLoS One 2011, 6:e14533.
3. Derfuss T., Parikh K., Velhin S., Braun M., Mathey E., Krumbholz M., Kumpfel T., Moldenhauer A., Rader C., Sonderegger P., Pollmann W., Tiefenthaller C., Bauer J., Lassmann H., Wekerle H., Karagogeos D., Hohlfeld R., Linington C., Meinl E. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:8302-8307.
4. Devaux J.J., Odaka M., Yuki N. Nodal proteins are target antigens in Guillain-Barré syndrome. J. Peripher. Nerv. Syst. 2012, 17:62-71.
5. Eshed Y., Feinberg K., Poliak S., Sabanay H., Sarig-Nadir O., Spiegel I., Bermingham J.R., Peles E. Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier. Neuron 2005, 47:215-229.
6. Kawamura N., Yamasaki R., Yonekawa T., Matsushita T., Kusunoki S., Nagayama S., Fukuda Y., Ogata H., Matsuse D., Murai H., Kira J. Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology 2013, 81:714-722.
7. Kiernan M.C., Guglielmi J.M., Kaji R., Murray N.M., Bostock H. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 2002, 125:664-675.
8. Kokubun N., Nishibayashi M., Uncini A., Odaka M., Hirata K., Yuki N. Conduction block in acute motor axonal neuropathy. Brain 2010, 133:2897-2908.
9. Koller H., Kieseier B.C., Jander S., Hartung H.P. Chronic inflammatory demyelinating polyneuropathy. N. Engl. J. Med. 2005, 352:1343-1356.
10. Kuwabara S., Yuki N., Koga M., Hattori T., Matsuura D., Miyake M., Noda M. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann. Neurol. 1998, 44:202-208.
11. Lancaster E., Huijbers M.G., Bar V., Boronat A., Wong A., Martinez-Hernandez E., Wilson C., Jacobs D., Lai M., Walker R.W., Graus F., Bataller L., Illa I., Markx S., Strauss K.A., Peles E., Scherer S.S., Dalmau J. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann. Neurol. 2011, 69:303-311.
12. Lonigro A., Devaux J.J. Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis. Brain 2009, 132:260-273.
13. Mathey E.K., Derfuss T., Storch M.K., Williams K.R., Hales K., Woolley D.R., Al-Hayani A., Davies S.N., Rasband M.N., Olsson T., Moldenhauer A., Velhin S., Hohlfeld R., Meinl E., Linington C. Neurofascin as a novel target for autoantibody-mediated axonal injury. J. Exp. Med. 2007, 204:2363-2372.
14. Mathey E.K., Yan W., Yuki N., Ji Q., Yiannikas C., Pollard J.D. Neurofascin as a target antigen in peripheral demyelinating neuropathies. J. Peripher. Nerv. Syst. 2011, 16:S84.
15. McGonigal R., Rowan E.G., Greenshields K.N., Halstead S.K., Humphreys P.D., Rother R.P., Furukawa K., Willison H.J. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain 2010, 133:1944-1960.
16. Ng J.K., Malotka J., Kawakami N., Derfuss T., Khademi M., Olsson T., Linington C., Odaka M., Tackenberg B., Pruss H., Schwab J.M., Harms L., Harms H., Sommer C., Rasband M.N., Eshed-Eisenbach Y., Peles E., Hohlfeld R., Yuki N., Dornmair K., Meinl E. Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 2012, 79:2241-2248.
17. Pollard J.D., Armati P.J. CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology. J. Peripher. Nerv. Syst. 2011, 16:15-23.
18. Pruss H., Schwab J.M., Derst C., Gortzen A., Veh R.W. Neurofascin as target of autoantibodies in Guillain-Barré syndrome. Brain 2011, 134:e173.
19. Querol L., Nogales-Gadea G., Rojas-Garcia R., Martinez-Hernandez E., Diaz-Manera J., Suarez-Calvet X., Navas M., Araque J., Gallardo E., Illa I. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Ann. Neurol. 2013, 73:370-380.
20. Querol L., Nogales-Gadea G., Rojas-Garcia R., Diaz-Manera J., Pardo J., Ortega-Moreno A., Sedano M.J., Gallardo E., Berciano J., Blesa R., Dalmau J., Illa I. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 2014, 82:879-886.
21. Sherman D.L., Tait S., Melrose S., Johnson R., Zonta B., Court F.A., Macklin W.B., Meek S., Smith A.J., Cottrell D.F., Brophy P.J. Neurofascins are required to establish axonal domains for saltatory conduction. Neuron 2005, 48:737-742.
22. Stefferl A., Schubart A., Storch2 M., Amini A., Mather I., Lassmann H., Linington C. Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. J. Immunol. 2000, 165:2859-2865.
23. Susuki K., Rasband M.N., Tohyama K., Koibuchi K., Okamoto S., Funakoshi K., Hirata K., Baba H., Yuki N. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci. 2007, 27:3956-3967.
24. Van den Bergh P.Y., Hadden R.D., Bouche P., Cornblath D.R., Hahn A., Illa I., Koski C.L., Leger J.M., Nobile-Orazio E., Pollard J., Sommer C., van Doorn P.A., van Schaik I.N. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society: first revision. Eur. J. Neurol. 2010, 17:356-363.
25. Yan W.X., Archelos J.J., Hartung H.P., Pollard J.D. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann. Neurol. 2001, 50:286-292.
26. Yuki N., Hartung H.P. Guillain-Barré syndrome. N. Engl. J. Med. 2012, 366:2294-2304.
27. Yuki N., Tagawa Y., Irie F., Hirabayashi Y., Handa S. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α. J. Neuroimmunol. 1997, 74:30-34.